Staar Surgical (STAA) FY2019 results: revenue $150 million, up 21.2% on the year
Staar Surgical Co. (STAA) reported revenue of $150 million for fiscal 2019, the year ended 3 January 2020, up 21.2% on the year before. Net income was $14 million, up 182.8%, and diluted earnings per share $0.30. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2020.
Revenue
$150 million
+21.2% on the year
FY2012FY2019
Operating margin
7.9%
5.3% a year earlier
FY2012FY2019
Net income
$14 million
+182.8% on the year
FY2012FY2019
Diluted EPS
$0.30
+172.7% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
150
124
90.6
+21.2%
Cost of revenue
38.2
32.4
26.3
+17.8%
Gross profit
112
91.5
64.3
+22.3%
Gross margin
74.5%
73.8%
70.9%
Research and development
25.3
22.0
20.0
+14.8%
Selling, general and administrative
100
84.9
67.9
+17.9%
Operating income
11.9
6.6
-3.6
+79.7%
Operating margin
7.9%
5.3%
-4.0%
Interest expense
n/a
n/a
0.1
Pre-tax income
13.0
6.6
-2.3
+96.2%
Income tax
-1.0
1.7
-0.2
Effective tax rate
-7.8%
25.2%
n/a
Net income
14.0
5.0
-2.1
+182.8%
Net margin
9.4%
4.0%
-2.4%
Diluted EPS
$0.30
$0.11
-$0.05
+172.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
25.8
12.8
2.9
+102.0%
Capital expenditure
10.1
2.2
1.0
+349.7%
Free cash flow
15.7
10.5
1.8
+49.2%
Free cash flow margin
10.5%
8.5%
2.0%
Cash from investing
-10.2
-2.2
-1.0
Cash from financing
0.1
74.6
2.4
-99.8%
Depreciation and amortisation
3.7
2.5
3.4
+50.1%
Share-based compensation
10.5
6.8
3.2
+56.0%
Diluted shares, weighted
47m
45m
41m
+3.6%
Shares outstanding at period end
45m
44m
41m
+1.4%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
160
132
42.9
+20.7%
Debt
1.8
3.8
4.4
-51.7%
Operating lease liabilities
4.1
n/a
n/a
Finance lease liabilities
0.4
0.5
n/a
-20.3%
Other liabilities
41.4
30.7
20.6
+34.8%
Total liabilities and equity
208
167
67.9
+24.0%
Fixed assets
17.1
11.5
9.8
+49.0%
Goodwill
1.8
1.8
1.8
0.0%
Intangible assets
0.3
0.2
0.3
+21.8%
Cash and equivalents
120
104
18.5
+15.5%
Receivables
31.0
25.9
17.9
+19.5%
Other assets
37.4
24.0
19.7
+55.6%
Total assets
208
167
67.9
+24.0%
10-K for the year ended 3 January 2020, filed 26 February 2020: the filing.